The Structural Formula Of Chlordiazepoxide Hydrochloride. (Chlordiazepoxide Hydrochloride And Clindinium Brom 01)
Chlordiazepoxide Hydrochloride And Clidinium Bromide
Product Images NDC 10135-622
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Chlordiazepoxide Hydrochloride And Clidinium Bromide (NDC 10135-622). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Marlex Pharmaceuticals Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
The Structural Formula Of Clidinium Bromide. (Chlordiazepoxide Hydrochloride And Clindinium Brom 02)
Principal Display Panelndc 10135-0622-01chlordiazepoxidehcl And Clidiniumbromide Capsules5 mg / 2.5 mgrx Only100 Capsules (Chlordiazepoxide Hydrochloride And Clindinium Brom 03)
This is a description of a medication called MarLEx. It contains Chlortazeporide HCI and Cidiium Bromide. The usual dosage information is not provided in this text, but the medicine should be kept out of reach of children and stored at room temperature. The medication is dispensed in tamper-evident capsules and should be kept in a high resistant container. The manufacturer of this medication is Marlex Pharmaceuticals, Inc., and it comes in a package of 100 capsules. The text provides a lot number and expiration date, as well as a warning not to use if the seal under the cap is broken or missing.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
